Trial Profile
A Study of the Efficacy and Tolerability of Once Daily Celebrex (Celecoxib) and Three Times Daily Ibuprofen vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Ibuprofen
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Pfizer; Viatris
- 11 Dec 2017 New trial record
- 01 Dec 2017 Results (n=441) of analysis comparing safety and efficacy of celecoxib with placebo in Asian and Non Asian population using patient data from A3191052 and A3191063 trials published in the Pain and Therapy